… Over 90% of the patients who received intravenous amiodarone in controlled clinical trials
went on to receive oral therapy. This conversion rate was high because the patients had …

… the influence of renal dysfunction on the disposition of amiodarone and its metabolite, …
mg/kg intravenous dose of amiodarone over 15 minutes. Of the 30, 11 had normal renal function (…

… Particular emphasis was placed on studies pertaining to the use of intravenous amiodarone
in treatment-refractory ventricular fibrillation (VF) and hemodynamically unstable ventricular …

… hyperacute drug toxicity caused by IV amiodarone being a distinctly different … amiodarone
and support the suggestion that oral amiodarone can be safely administered even in patients …

… arrhythmias because of amiodarone's rapid onset of action … intravenous amiodarone and
define the role of amiodarone … renal disease, hepatic disease, or left ventricular dysfunction, …

… failure (ALF) and died of multiple organ failure (MOF). The other patient was admitted to
our emergency department due to PAF. Intravenous amiodarone … and acute renal failure (ARF). …

… amiodarone after resolution of acute hepatic failure. Regarding acute renal failure with IV
amiodarone … of creatinine is 8.8% in patients on oral amiodarone with mean increase of 0.81 mg…

… By 48 h postcessation of intravenous amiodarone, liver function had dramatically improved.
Kidney function responded well to haemofiltration. The patient was transferred back to …

… We attempted to assess whether comorbidities such as chronic kidney disease and
congestive heart failure played a role in developing severe elevation of liver enzymes, but no …

The disposition of amiodarone, an … intravenous infusion (5 mg/kg over 15 minutes) in patients
of various ages and with various degrees of renal function and left ventricular function. The …